ASPR releases planning tool for COVID-19 monoclonal antibody infusion sites

The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response yesterday released an online calculator to help clinicians and health care facilities increase their capacity to administer monoclonal antibodies to patients with mild or moderate COVID-19 who are at risk for progressing to severe disease and hospitalization.
“While vaccines are playing a vital role in driving down cases, monoclonal antibodies continue to be critical tool for improving outcomes for people who become infected with SARS-COV-2,” said ASPR Chief Medical Officer John Redd, M.D. “Clinicians in every community need to be ready to identify, refer, and treat high-risk patients, and this calculator can help.”
Related News Articles
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…